Top Markets
Coin of the day
Mycenax Biotech Inc. Mycenax Biotech Inc.

Mycenax Biotech Inc.

4726
Pozycja w akcjach #19467
Mycenax Biotech Inc. specializes in the research, development, and... Mycenax Biotech Inc. specializes in the research, development, and manufacturing of biopharmaceutical products, leveraging both mammalian and microbial cell culture systems. Its market reach extends across Taiwan, Europe, Asia, and the United States. The company cultivates a diverse portfolio of advanced biological therapeutics and components. This includes monoclonal antibodies, bi-specific antibodies, Fc-fusion proteins, recombinant proteins, peptides, non-toxic protein conjugates, antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), in addition to plasmids and DNA vaccines. Beyond product innovation, Mycenax offers a comprehensive suite of process development solutions. These encompass the establishment of production cell lines, optimization of upstream and downstream processes, industrial scale-up, formulation science, and the creation of analytical methods. The firm also provides in-house analytical testing, Good Manufacturing Practice (GMP)-compliant manufacturing services for drug substances and finished products, and cell banking, all underpinned by its specialized manufacturing technologies. Established in 2001, Mycenax Biotech Inc. is headquartered in Zhubei, Taiwan.
Cena akcji
$0.77907619
Kapitalizacja rynkowa
$161.30M
Zmiana (1 dzień)
0.41%
Zmiana (1 rok)
-37.18%
Kraj
TW
Handel Mycenax Biotech Inc. (4726)

Kategoria

Historia stopy dywidendy dla Mycenax Biotech Inc. (4726)
Stopa dywidendy (TTM) dla Mycenax Biotech Inc. (symbol akcji: 4726) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Mycenax Biotech Inc. (4726) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji